Biotech Late Stage Investors & VC Firms
652 firms in this list, with a median first check of $1M. 131 of them lead rounds. Generated from verified public data and updated continuously.
Nextech Invest
ZurichSeed–Late Stage$648K – $3.2M
3 people
Transform Capital Management
San FranciscoSeed–Late Stage
15 people
Owl Rock Capital
New YorkGrowth–Late Stage$20M – $250M
20 people
Magnum Industrial Partners Tres S.L.
MadridGrowth–Late Stage
17 people
T. Rowe Price
BaltimoreSeed–Late Stage
1 person
Thorney Investment Group
MelbourneSeed–Late Stage
25 people
Eurazeo
ParisSeries A–Late Stage
12 people
Hiroshima Venture Capital Co. Ltd.
HiroshimaPre-Seed–Late Stage
GSR United Capital
BeijingSeed–Late Stage$98K – $50M
Lauxera Capital Partners
ParisGrowth–Late Stage$22M – $110M
18 people
Dimension Capital
San FranciscoSeed–Late Stage$1M – $10M
14 people
New Alliance Capital
ShanghaiSeed–Late Stage
25 people
Keensight Capital
ParisGrowth–Late Stage$10M – $800M
5 people
Limburgse Reconversie Maatschappij
HasseltSeed–Late Stage$27K – $10.8M
22 people
BIOSPRING PARTNERS
New YorkGrowth–Late Stage
22 people
Quan Capital
ShanghaiSeed–Late Stage
16 people
Asahi Kasei Corporate Venture Capital
Menlo ParkPre-Seed–Late Stage$500K – $3M
21 people
Accelmed Partners
MiamiPre-Seed–Late Stage
10 people
Sixty Degree Capital
North YorkPre-Seed–Late Stage
16 people
Verdex Capital
CalgaryPre-Seed–Late Stage
10 people
Mountain Group Capital
NashvillePre-Seed–Late Stage
13 people
SQN Venture Partners, LLC
CharlestonSeed–Late Stage
8 people
JK&B Capital
ChicagoPre-Seed–Late Stage
9 people
LYFE Capital
Menlo ParkSeed–Late Stage
16 people
Related lists
Late Stage Investors & VC Firms (2974)Biotech Investors & VC Firms (2185)Biotech Seed Investors & VC Firms (1824)Late Stage Investors & VC Firms in North America (1695)Biotech Series A Investors & VC Firms (1668)Late Stage Investors & VC Firms in United States (1516)Biotech Investors & VC Firms in North America (1391)Biotech Investors & VC Firms in United States (1267)Late Stage Investors & VC Firms in Europe (965)Biotech Pre-Seed Investors & VC Firms (957)
Data sourced from public filings and firms' own websites — see our methodology.












































































